157 related articles for article (PubMed ID: 8894739)
21. Redox active iron accumulation in aceruloplasminemia.
Gonzalez-Cuyar LF; Perry G; Miyajima H; Atwood CS; Riveros-Angel M; Lyons PF; Siedlak SL; Smith MA; Castellani RJ
Neuropathology; 2008 Oct; 28(5):466-71. PubMed ID: 18282164
[TBL] [Abstract][Full Text] [Related]
22. Phenotypic heterogeneity in seven Italian cases of aceruloplasminemia.
Pelucchi S; Mariani R; Ravasi G; Pelloni I; Marano M; Tremolizzo L; Alessio M; Piperno A
Parkinsonism Relat Disord; 2018 Jun; 51():36-42. PubMed ID: 29503155
[TBL] [Abstract][Full Text] [Related]
23. Glucose and oxygen hypometabolism in aceruloplasminemia brains.
Miyajima H; Takahashi Y; Kono S; Sugimoto M; Suzuki Y; Hishida A; Sakamoto M; Ouchi Y
Intern Med; 2002 Mar; 41(3):186-90. PubMed ID: 11929178
[TBL] [Abstract][Full Text] [Related]
24. Hereditary ceruloplasmin deficiency with hemosiderosis.
Okamoto N; Wada S; Oga T; Kawabata Y; Baba Y; Habu D; Takeda Z; Wada Y
Hum Genet; 1996 Jun; 97(6):755-8. PubMed ID: 8641692
[TBL] [Abstract][Full Text] [Related]
25. Novel ceruloplasmin mutation causing aceruloplasminemia with hepatic iron overload and diabetes without neurological symptoms.
Rusticeanu M; Zimmer V; Schleithoff L; Wonney K; Viera J; Zimmer A; Hübschen U; Bohle RM; Grünhage F; Lammert F
Clin Genet; 2014 Mar; 85(3):300-1. PubMed ID: 23557349
[No Abstract] [Full Text] [Related]
26. Increased very long-chain fatty acids in erythrocyte membranes of patients with aceruloplasminemia.
Miyajima H; Adachi J; Tatsuno Y; Takahashi Y; Fujimoto M; Kaneko E; Gitlin JD
Neurology; 1998 Jan; 50(1):130-6. PubMed ID: 9443469
[TBL] [Abstract][Full Text] [Related]
27. [Aceruloplasminemia (hereditary ceruloplasmin deficiency) and diabetes mellitus].
Momoki T; Terauchi Y
Nihon Rinsho; 2006 Sep; Suppl 3():100-4. PubMed ID: 17022509
[No Abstract] [Full Text] [Related]
28. Aceruloplasminemia with juvenile-onset diabetes mellitus caused by exon skipping in the ceruloplasmin gene.
Hatanaka Y; Okano T; Oda K; Yamamoto K; Yoshida K
Intern Med; 2003 Jul; 42(7):599-604. PubMed ID: 12879954
[TBL] [Abstract][Full Text] [Related]
29. A novel splicing mutation in the ceruloplasmin gene responsible for hereditary ceruloplasmin deficiency with hemosiderosis.
Yazaki M; Yoshida K; Nakamura A; Furihata K; Yonekawa M; Okabe T; Yamashita N; Ohta M; Ikeda S
J Neurol Sci; 1998; 156(1):30-4. PubMed ID: 9559983
[TBL] [Abstract][Full Text] [Related]
30. Aceruloplasminemia: a novel mutation in a family with marked phenotypic variability.
Fasano A; Colosimo C; Miyajima H; Tonali PA; Re TJ; Bentivoglio AR
Mov Disord; 2008 Apr; 23(5):751-5. PubMed ID: 18200628
[TBL] [Abstract][Full Text] [Related]
31. Aceruloplasminemia presents as Type 1 diabetes in non-obese adults: a detailed case series.
Vroegindeweij LH; van der Beek EH; Boon AJ; Hoogendoorn M; Kievit JA; Wilson JH; Langendonk JG
Diabet Med; 2015 Aug; 32(8):993-1000. PubMed ID: 25661792
[TBL] [Abstract][Full Text] [Related]
32. Genetic and Clinical Heterogeneity in Thirteen New Cases with Aceruloplasminemia. Atypical Anemia as a Clue for an Early Diagnosis.
Vila Cuenca M; Marchi G; Barqué A; Esteban-Jurado C; Marchetto A; Giorgetti A; Chelban V; Houlden H; Wood NW; Piubelli C; Dorigatti Borges M; Martins de Albuquerque D; Yotsumoto Fertrin K; Jové-Buxeda E; Sanchez-Delgado J; Baena-Díez N; Burnyte B; Utkus A; Busti F; Kaubrys G; Suku E; Kowalczyk K; Karaszewski B; Porter JB; Pollard S; Eleftheriou P; Bignell P; Girelli D; Sanchez M
Int J Mol Sci; 2020 Mar; 21(7):. PubMed ID: 32235485
[TBL] [Abstract][Full Text] [Related]
33. Ceruloplasmin replacement therapy ameliorates neurological symptoms in a preclinical model of aceruloplasminemia.
Zanardi A; Conti A; Cremonesi M; D'Adamo P; Gilberti E; Apostoli P; Cannistraci CV; Piperno A; David S; Alessio M
EMBO Mol Med; 2018 Jan; 10(1):91-106. PubMed ID: 29183916
[TBL] [Abstract][Full Text] [Related]
34. MR imaging of cerebral cortical involvement in aceruloplasminemia.
Grisoli M; Piperno A; Chiapparini L; Mariani R; Savoiardo M
AJNR Am J Neuroradiol; 2005 Mar; 26(3):657-61. PubMed ID: 15760883
[TBL] [Abstract][Full Text] [Related]
35. Aceruloplasminemia.
Gitlin JD
Pediatr Res; 1998 Sep; 44(3):271-6. PubMed ID: 9727700
[TBL] [Abstract][Full Text] [Related]
36. Criteria for early identification of aceruloplasminemia.
Ogimoto M; Anzai K; Takenoshita H; Kogawa K; Akehi Y; Yoshida R; Nakano M; Yoshida K; Ono J
Intern Med; 2011; 50(13):1415-8. PubMed ID: 21720062
[TBL] [Abstract][Full Text] [Related]
37. Aceruloplasminemia.
Miyajima H
Neuropathology; 2015 Feb; 35(1):83-90. PubMed ID: 25168455
[TBL] [Abstract][Full Text] [Related]
38. Teaching NeuroImages: neurodegeneration with brain iron accumulation in aceruloplasminemia.
Parks NE; Vandorpe RA; Moeller JJ
Neurology; 2013 Nov; 81(20):e151-2. PubMed ID: 24218322
[TBL] [Abstract][Full Text] [Related]
39. MR imaging for the quantitative assessment of brain iron in aceruloplasminemia: A postmortem validation study.
Vroegindeweij LHP; Wielopolski PA; Boon AJW; Wilson JHP; Verdijk RM; Zheng S; Bonnet S; Bossoni L; van der Weerd L; Hernandez-Tamames JA; Langendonk JG
Neuroimage; 2021 Dec; 245():118752. PubMed ID: 34823024
[TBL] [Abstract][Full Text] [Related]
40. Cerebellar ataxia associated with heteroallelic ceruloplasmin gene mutation.
Miyajima H; Kono S; Takahashi Y; Sugimoto M; Sakamoto M; Sakai N
Neurology; 2001 Dec; 57(12):2205-10. PubMed ID: 11756598
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]